Finally, we validated the efficacy of treatments targeting disrupted mitochondrial protein importation by upregulating SIRT5 expression or MB administration in the compression-induced rat IDD model, providing a new therapeutic strategy for IDD. The gene discussed is SIRT5; the disease is intervertebral disk degenerative disorder.